Publisher Correction: Trastuzumab deruxtecan in HER2-positive advanced breast cancer with or without brain metastases: a phase 3b/4 trial(Nature Medicine, 10.1038/s41591-024-03261-7)

Publikation: Spezielle Publikationen/BeiträgeKorrekturen (Errata und Widerrufe)Begutachtung

Beitragende

  • the DESTINY-Breast12 study group - (Autor:in)
  • Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe
  • Ludwig-Maximilians-Universität München (LMU)
  • Hospital Universitario 12 de Octubre
  • University of Liege
  • Universität Hamburg
  • Tokai University
  • IRCCS Istituto Europeo di Oncologia - Milano
  • Medizinische Universität Wien
  • Universität Basel
  • Ospidéal Ollscoile Naomh Uinseann
  • University College Cork
  • Royal North Shore Hospital
  • Hospital Beata María Ana
  • Hospital Ramon y Cajal
  • Università degli studi di Padova
  • IRCCS Istituto Oncologico Veneto - Padova
  • IRCCS Ospedale San Raffaele - Milano
  • Vita-Salute San Raffaele University
  • KU Leuven
  • Vall d'Hebron Institute of Oncology (VHIO)
  • AstraZeneca
  • Dana-Farber Cancer Institute
  • Duke University
  • University of Edinburgh
  • Université de Lausanne
  • Luzerner Kantonsspital
  • Ente Ospedaliero Cantonale (EOC)
  • Sahlgrenska University Hospital
  • Lund University
  • Uppsala University
  • Hospital de Basurto
  • Hospital Universitario Marques de Valdecilla
  • Hospital Universitario Virgen de las Nieves
  • Hospital Clínico Universitario de Salamanca
  • University of Santiago de Compostela
  • Krankenhaus Ruber Internacional
  • Hospital Universitario Virgen del Rocio
  • Hospital Universitario de la Princesa
  • Instituto Valenciano de Oncologia (IVO)
  • University Hospital of Bellvitge
  • Hospital Clínic de Barcelona
  • Hospital de Santa Maria-Centro Hospitalar Lisboa Norte (CHLN)
  • Champalimaud Foundation
  • Universidade do Porto
  • Centralny Szpital Kliniczny Wojskowej Akademii Medycznej z Poliklinika
  • Uniwersyteckie Centrum Kliniczne Gdansk
  • Opolskie Centrum Onkologii im. prof. T. Koszarowskiego
  • Maria Sklodowska-Curie Institute of Oncology
  • Krakow University Hospital
  • Universitätsklinikum Carl Gustav Carus Dresden

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-024-03261-7, published online 13 September 2024. In the version of this article initially published, members of the DESTINY-Breast12 study group were not included by the journal in the full text. In Table 1, under the “Prior CNS therapies n (%)” section, seven rows have been added, in addition to the original CNS radiotherapy, WBRT and SRS rows. In Table 1 and in the Results: Patients section, “intracranial therapy” has been amended to “CNS radiotherapy,” while the text “the type of intracranial radiotherapy was not always recorded by investigators, and only WBRT and SRS intracranial radiotherapy were reported” has been removed. All changes appear in the HTML and PDF versions of the article.

Details

OriginalspracheEnglisch
Seiten3780
Seitenumfang1
Band30
Ausgabenummer12
FachzeitschriftNature medicine
PublikationsstatusVeröffentlicht - Dez. 2024
Peer-Review-StatusJa
No renderer: customAssociatesEventsRenderPortal,dk.atira.pure.api.shared.model.researchoutput.ContributionToPeriodical

Externe IDs

PubMed 39653780

Schlagworte